RT
KRYS icon

Robert Torray’s Krystal Biotech KRYS Stock Holding History

Robert Torray’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52M Buy
12,156
+124
+1% +$37K 0.61% 40
2026
Q1 		$3.11M Buy
12,032
+47
+0.4% +$12.5K 0.46% 45
2025
Q4 		$2.95M Buy
11,985
+84
+0.7% +$17.7K 0.42% 51
2025
Q3 		$2.1M Buy
11,901
+327
+3% +$48.9K 0.29% 60
2025
Q2 		$1.59M Buy
+11,574
New +$1.7M 0.23% 68

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Robert Torray's KRYS Position: Q2 2026 in Review

Robert Torray increased its Krystal Biotech (KRYS) stake by 1% in Q2 2026, buying an estimated $37K and bringing the position to 12,156 shares worth $4.52M. The position accounts for 0.61% of the portfolio, ranked #40.

Robert Torray first reported a position in KRYS in Q2 2025 and has held it in 5 quarters since. 420 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Robert Torray held 12,156 shares of Krystal Biotech worth $4.52M as of Q2 2026.
  • Robert Torray bought 124 Krystal Biotech shares in Q2 2026, an estimated $37K.
  • Krystal Biotech made up 0.61% of Robert Torray's portfolio in Q2 2026, its #40 holding.
  • Robert Torray first reported a position in Krystal Biotech in Q2 2025 and has held it in 5 quarters since.
  • 420 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Torray Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.